Phase II study of sunitinib malate in head and neck squamous cell carcinoma.
Choong NW, Kozloff M, Taber D, Hu HS, Wade J 3rd, Ivy P, Karrison TG, Dekker A, Vokes EE, Cohen EE.
Choong NW, et al.
Invest New Drugs. 2010 Oct;28(5):677-83. doi: 10.1007/s10637-009-9296-7. Epub 2009 Aug 4.
Invest New Drugs. 2010.
PMID: 19649772
Clinical Trial.